Heron Therapeutics | HRTX - Eps Gewinn Pro Aktie

Aktienkurs
0.80
Täglich Wechseln
0.02 2.32%
Monatlich
-26.87%
Jährlich
-67.20%
Q1 Prognose
0.76




Eps Veränderung Datum
ALKERMES USD 0.29 0.2 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.14 0.06 2025-12
ANI Pharmaceuticals USD 2.33 0.29 2025-12
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
Eisai JPY 60.94 24.92 2025-12
Emergent BioSolutions USD -0.77 0.29 2023-12
Esperion Therapeutics USD 0.26 0.42 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -1.54 0.21 2025-12
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
Merck USD 2.04 0.54 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Omeros USD -1.12 0.37 2024-06
Pacira USD 0.06 0.64 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Surmodics USD -0.25 0.28 2024-09
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Veracyte USD 0.53 0.02 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12